Healthcare Marketing

Swoop Swoop

From Signals to Outcomes: 5 Healthcare Trends Shaping the Information Age

Industry leaders at SXSW 2026 explored how AI, data, and evolving patient behaviors redefine the pharma marketing landscape.
Marcella Milliet Sciorra Marcella Milliet Sciorra

The Future of Rare Disease Marketing is Patient-First and Privacy-Safe 

Swoop helps brands find, engage, and support rare disease patients earlier through privacy-safe, data-driven solutions.

Communities | Product Overviews

Swoop Swoop

Smarter Intelligence, Deeper Connection: Redefining Brand Marketing in 2026 

Swoop's 2026 innovations build a truly patient-first marketing strategy.
Eric Peacock Eric Peacock

Why AI is Fueling the Growth of Patient Communities 

Google’s shift toward AI-generated answers removes blue search links often without clear attribution or context.
Swoop Swoop

83% of Chronic Condition Patients Surveyed Find Pharma Ads Beneficial 

Patient Perspectives on Pharmaceutical Advertising: Exclusive Insights from Swoop 
Marcella Milliet Sciorra Marcella Milliet Sciorra

This is how Swoop is Redefining Healthcare Marketing. Again. 

A privacy-safe marketing ecosystem that connects patients, healthcare providers, and brands to drive better health outcomes. 
Swoop Swoop

Data and Storytelling in Cannes: The New Era of Healthcare TV Advertising 

A powerhouse media, pharma, and data panel shares healthcare advertising insights, experiences, and predictions
Katie Carr Katie Carr

Are traditional measuring solutions keeping up with the pace of modern healthcare audience targeting?

Some legacy leaders in healthcare measurement methodology have not kept pace with advancements in audience targeting, creating significant gaps in accuracy
Swoop Swoop

DSP Diagnosis: 10 Factors Pharma Marketers Should Consider

This checklist will guide you through choosing a DSP that aligns with your objectives, respects patient privacy, and leverages cutting-edge technology.
Swoop Swoop

Five fast lessons from Reuters Pharma USA 2025

Here are five quick takeaways from Reuters Pharma USA 2025
1 2 3 4